Novocure announces final patient enrolled in METIS study

Novocure announced that the final patient has enrolled in the pivotal METIS study evaluating the efficacy of Tumor Treating Fields, or TTFields, therapy following stereotactic radiosurgery for treatment of patients with brain metastases resulting from non-small cell lung cancer.